Myanmar vs Netherlands: New cases tested for RR-/MDR-TB
Myanmar
91.0%
in 2024
Netherlands
91.0%
in 2024
Myanmar rank
91st
Netherlands rank
91st
New cases tested for RR-/MDR-TB over time
- Myanmar
- Netherlands
How they compare
Myanmar currently reports 91.0% against 91.0% in Netherlands, a difference of 0.0%.
The two have swapped places 2 times across 11 shared years of data; in 2012 it was Netherlands ahead.
Myanmar ranks 91st and Netherlands ranks 91st of 192 countries.
Netherlands has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Myanmar | Netherlands | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 43.8% | 95.1% | 51.3% | Netherlands |
| 2020s | 83.3% | 90.0% | 6.7% | Netherlands |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Myanmar or Netherlands?
- Myanmar, at 91.0% against 91.0% in Netherlands as of 2024.
- What is the difference in new cases tested for rr-/mdr-tb between Myanmar and Netherlands?
- 0.0%, with Myanmar ahead.
- How many years of comparable data are there for Myanmar and Netherlands?
- 11 years are reported by both, from 2012 to 2024.
- How do Myanmar and Netherlands rank globally for new cases tested for rr-/mdr-tb?
- Myanmar ranks 91st and Netherlands ranks 91st of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.